ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Weekly Digest

Downgrades Dominate a Bruising Week for Intel and Housing

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 4 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The street turned decisively negative this week. Downgrades outnumbered upgrades by a wide margin across the five trading days from October 26. Intel drew the most analyst attention, collecting multiple cuts in a single session. Housing-related names and consumer-facing stocks also faced concentrated selling pressure from the analyst community.

Key Rating Changes

Upgrades

INTC drew a rare bright spot early in the week. New Street Research analyst Pierre Ferragu lifted the stock to Buy with a $125 target, up from Neutral, citing opportunity at $87. KGI Securities followed with an Outperform call and a $95 target.

LMT received a Morgan Stanley upgrade to Overweight. The firm raised its target to $835 from $690, implying 38% upside from around $604. The stock had already gained 9.4% in the prior week.

TSLA was lifted to Overweight by Barclays, with a new $450 target up from $370.

BAH got a TD Cowen upgrade to Buy. The target moved to $95 from $77, implying 21% upside.

ROP was lifted to Neutral from Underweight by JP Morgan, target raised 18% to $490, after the stock jumped 14.5% on an earnings beat.

LKQ was upgraded to Overweight by Barclays with a $25 target. The stock had fallen 22% in October.

RIVN was upgraded to Buy by Jefferies. Analyst Philippe Houchois set a $17 target, implying 48% upside from $11.45, citing R2 demand confidence despite 13.7% short interest.

BIIB was lifted to Buy by Argus Research with a $280 target. Short interest on the stock has eased to 3.8% of float.

MPWR received a Buy call from Rosenblatt, target raised to $1,700 from $1,575, implying 42% upside.

HLT was upgraded by Mizuho, target lifted 28% to $421, on strong RevPAR growth and EBITDA performance.

GEV was lifted to Buy by HSBC, target raised to $1,100 from $1,040.

Other upgrades included NWE to Overweight at Wells Fargo, WTFC to Buy at UBS, FERG to Buy at Citigroup, RCL to Buy at Freedom Broker, CHE to Buy at Jefferies, and INCY to Outperform at Oppenheimer.


Downgrades

INTC dominated the downgrade list. Bank of America cut to Neutral, target slashed to $100 from $145. Roth Capital cut to Neutral, halving its target to $70 from $120. Seaport Global moved to Neutral from Buy. That is three cuts in a single session, with foundry execution risk and weak PC demand cited across all three.

CART attracted four separate downgrades in one day. Needham, Barclays, Citizens, and Bernstein all pulled back ratings. Barclays cut its target to $65 from $77. Margin pressure was the common thread, even as the stock had risen 32% in the prior month.

ALNY fell 25% after Raymond James cut to Outperform with a target of $315, down from $420. Bernstein followed, slashing its target to $199 from $376.

FND was cut by two firms. Stifel downgraded to Hold from Buy, target cut 31% to $52. Telsey moved to Market Perform, target cut 26% to $50. Analyst Carter cited weakening fundamentals and category headwinds.

ALKT was downgraded twice in two days, by Keybanc and then Citizens, the third major cut this quarter amid activist pressure.

COUR was cut by Keybanc and JP Morgan. JP Morgan's target fell to $5 from $8. Short interest stands at 14.8% of float, up 5.1% in the past week.

RDDT was downgraded by both Keybanc and Citizens ahead of earnings.

BLDR and BCC were both cut to Hold by Loop Capital's Jeffrey Stevenson, citing deteriorating housing fundamentals.

MPT was cut to Underperform by RBC, target slashed 56% to $2.00 from $4.50. Short interest sits at 24.9% of float.

WHR was cut to Sell by Stifel, target reduced to $20 from $30.

PYPL was downgraded to Underweight by Barclays, target cut to $53, on margin pressure and competitive losses in checkout.

GSK was cut to Hold by Jefferies, target reduced to 55.9 from 67.4. Short interest has risen 14% in the past month.

SFM was cut to Sector Perform by RBC Capital, target slashed to $49 from $111, on Cyclospora impact and fuel costs.

Further downgrades hit EFX at RBC, GOOGL at Citizens, MBLY at TD Cowen, SYK at Canaccord, BSX at both Jefferies and TD Cowen, HSY at TD Cowen, HUBS at UBS, UWMC at Compass Point, BBD at Citigroup and JP Morgan, and MTB at Wolfe Research.


Sector Themes

Semiconductors Under Pressure

Intel is the defining story. Three firms cut ratings in a single session on October 30. The consensus concern is foundry execution risk alongside softening PC demand. The stock sits 30% below its late-September peak. One counter-call came from KGI Securities, but the balance of opinion shifted sharply negative.

Housing Names Broadly Retreated

Loop Capital cut both BLDR and BCC to Hold. FND received cuts from two separate firms. The common language across these notes is deteriorating housing fundamentals and demand headwinds into year-end.

Financials: Regional Banks Face Scrutiny

Regional banking names drew multiple downgrades. MTB was cut to Underperform by Wolfe Research. BOH was cut by KBW on margin sustainability concerns. RNST was downgraded by Raymond James. HOPE was cut by DA Davidson. Weak loan growth and slowing deposit trends were cited repeatedly.

Delivery and Consumer Tech Retreat

CART saw four downgrades in one session. PYPL was cut on competitive pressure. GOOGL drew a Citizens downgrade. Analysts across consumer-facing tech names are pulling back conviction as margin concerns mount heading into year-end reporting.

Stocks in this article

How this article was generated

Generated
2 Nov 2026, 13:26
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.